The Venture Codex Logo

The Venture Codex

VisVires New Protein

110 Amoy Street #02-01, Singapore, Central Singapore, 069930

Overview

Venture capital firm investing in transformative new protein solutions.

Founded

2016

Deals · 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B

Geographic focus

France
Germany
Ireland
Israel
...

Sector focus

AgTech
Aquaculture
Food and Beverage
Food Processing
...

Investment portfolio

19rounds
NAMEDATESIZE
Scindo
Sep 2025Led
$5 MOther Equity
NxtFood
Sep 2025Participated
$58 MOther Equity
MiAlgae
Sep 2024Participated
$18 MOther Equity
Abolis Biotechnologies
Sep 2024Participated
$39 MOther Equity
WeedOut
Feb 2024Participated
$8 MSeries A
Infinite Roots
Jan 2024Participated
$58 MSeries B
TOOPI Organics
Sep 2023Led
$12 MSeries A
Nuritas
Nov 2021Participated
$45 MSeries B
Collectiv Food
Jul 2021Led
$16 MSeries A
Aleph Farms
Jul 2021Participated
$105 MSeries B
ViAqua Therapeutics
Jun 2021Participated
$3 MOther Equity
SwissDeCode
Jan 2021Led
$4 MOther Equity
Scindo
Sep 2025Led
$5 MOther Equity
NxtFood
Sep 2025Participated
$58 MOther Equity
MiAlgae
Sep 2024Participated
$18 MOther Equity
Abolis Biotechnologies
Sep 2024Participated
$39 MOther Equity
WeedOut
Feb 2024Participated
$8 MSeries A
Infinite Roots
Jan 2024Participated
$58 MSeries B
TOOPI Organics
Sep 2023Led
$12 MSeries A
Nuritas
Nov 2021Participated
$45 MSeries B
Collectiv Food
Jul 2021Led
$16 MSeries A
Aleph Farms
Jul 2021Participated
$105 MSeries B
ViAqua Therapeutics
Jun 2021Participated
$3 MOther Equity
SwissDeCode
Jan 2021Led
$4 MOther Equity
19
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

VisVires New Protein: 19 funding rounds are recorded in the selected participation categories.All available history.
VisVires New Protein: 19 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A51
Series B04
Other Equity45

Monthly Deal Activity

VisVires New Protein: 19 deals are recorded across 142 months.All available history.
VisVires New Protein: 19 deals are recorded across 142 months. All available history
MonthDeals
Jan '151
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '151
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '161
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '181
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '192
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '201
Sep '200
Oct '200
Nov '200
Dec '200
Jan '211
Feb '210
Mar '210
Apr '210
May '210
Jun '211
Jul '212
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '241
Feb '241
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '242
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '252
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

VisVires New Protein: Health & Life Sciences is the largest displayed sector by deal count (13 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

VisVires New Protein: Health & Life Sciences is the largest displayed sector by deal count (13 deals). All available history
SectorDeals
Health & Life Sciences13
Food & Agriculture13
Clean Energy & Sustainability5
Space & Frontier Tech3
Networks, Cloud & Communication3
AI & Machine Learning3
Data, Analytics & IT2
Manufacturing2
Government & Defense1
E-Commerce & Retail1
Real Estate & Construction1
Transportation & Logistics1
Consumer & Lifestyle1
Hardware & Robotics1
Fintech1

Deal Size Distribution

VisVires New Protein: 19 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

VisVires New Protein: 19 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M3
$5M-$10M4
$10M-$25M7
$25M-$50M2
$50M-$100M2
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

VisVires New Protein: Europe has the largest recorded deal count among the displayed regions (14 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

VisVires New Protein: Europe has the largest recorded deal count among the displayed regions (14 deals). All available history
RegionDeals
Europe14
Israel4
Singapore1
VisVires New Protein: 20 co-investors are shown, with Cargill sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

VisVires New Protein: 20 co-investors are shown, with Cargill sharing 2 recorded deals. All available history
Co-investorShared deals
Cargill2
CPT Capital2
Emertec2
Happiness Capital2
Peregrine Ventures2
Redalpine2
Strauss Group2
Thai Union2
AgFunder1
Agriline1
Betagro Ventures1
BNP Paribas Développement1
BPI Green Tech Investment1
BRF1
Bunge Ventures1
CJ CheilJedang1
Cleveland Avenue1
Colle Capital1
Creadev1
Cultivian Sandbox Ventures1

Investment Strategy

VisVires New Protein: Led accounts for 47% and participating for 53% of round participation.All available history.
VisVires New Protein: Led accounts for 47% and participating for 53% of round participation. All available history
CategoryDeals (count)Share (%)
Led947%
Participating1053%
VisVires New Protein: Single-lead accounts for 44% and co-led for 56% of lead dynamics.All available history.
VisVires New Protein: Single-lead accounts for 44% and co-led for 56% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead444%
Co-led556%

Team

Gerard Chia

Partner

Kenneth Lee

Managing Director

Matthieu Vermersch

Founder and Managing Director